Related Experiment Videos

[Non-tubercular bacterial meningitis in children in Antananarivo, Madagascar]

R Migliani1, J Clouzeau, J W Decousser

  • 1Institut Pasteur, BP 1274, Antananarivo, Madagascar. rmiglian@pasteur.mg

Insights

Bacterial meningitis in children is primarily caused by Streptococcus pneumoniae and Haemophilus influenzae b. Early vaccination against H. influenzae and prompt antibiotic treatment are crucial for reducing severe complications and mortality.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Bacterial meningitis poses a significant threat to children's health, particularly in developing regions.
  • Identifying causative agents and their antimicrobial resistance patterns is vital for effective treatment and prevention strategies.

Purpose of the Study:

  • To identify the bacterial pathogens responsible for meningitis in children aged one month to 14 years.
  • To analyze the antimicrobial resistance patterns of these identified pathogens.

Main Methods:

  • A two-year prospective study was conducted in Antananarivo involving children with suspected bacterial meningitis.
  • Diagnostic methods included cerebrospinal fluid analysis, Gram staining, bacterial culture, and antimicrobial sensitivity testing.

Main Results:

  • Streptococcus pneumoniae (45%) and Haemophilus influenzae b (43%) were the predominant pathogens. Neisseria meningitidis accounted for 10% of cases.
  • While sensitive to penicillin G and third-generation cephalosporins, resistance to chloramphenicol and aminoglycosides was noted in S. pneumoniae, and resistance to gentamicin and amoxicillin in H. influenzae.
  • The study reported a high mortality rate of 31%, with 30% of survivors experiencing neurosensitive disorders.

Conclusions:

  • Vaccination against Haemophilus influenzae b should be integrated into Madagascar's national immunization program.
  • Early diagnosis and treatment with appropriate antibiotics, such as third-generation cephalosporins, are essential to mitigate severe outcomes of bacterial meningitis.
Abstract

Related Concept Videos